EA
57
-2
TRV
42
-6
CA
44
-10
MAT
41
-2
AXP
70
6
KR
56
11
BRK.B
31
-2
BA
63
5
DNB
60
2
HBI
48
3
HIG
52
-4
ECL
59
-3
DD
53
-7
ZTS
54
-4
LB
12
11
TXN
33
-7
FTI
69
-2
MPC
39
-2
AMAT
40
-3
SPG
51
-5
EA
57
-2
TRV
42
-6
CA
44
-10
MAT
41
-2
AXP
70
6
KR
56
11
BRK.B
31
-2
BA
63
5
DNB
60
2
HBI
48
3
HIG
52
-4
ECL
59
-3
DD
53
-7
ZTS
54
-4
LB
12
11
TXN
33
-7
FTI
69
-2
MPC
39
-2
AMAT
40
-3
SPG
51
-5
Financhill
Back

BioCryst Pharmaceuticals Quote, Financials, Valuation and Earnings

Better Than Oil Stocks

CLICK HERE TO FIND OUT MORE
Sell
40

BCRX
BioCryst Pharmaceuticals

Last Price:
7.87
Seasonality Move:
8.45%

7 Day Trial

ALL ACCESS PASS

$ 7

Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!

Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)

BioCryst Pharmaceuticals Price Quote

$7.87
-0.06 (-0.76%)
(Updated: December 11, 2024 at 5:55 PM ET)

BioCryst Pharmaceuticals Key Stats

Sell
40
BioCryst Pharmaceuticals (BCRX) is a Sell
Day range:
$7.68 - $8.00
52-week range:
$4.03 - $8.88
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
3.94
P/B ratio:
0%
Volume:
1.8M
Avg. volume:
2.3M
1-year change:
39.37%
Market cap:
$1.6B
Revenue:
$331.4M
EPS:
$-0.61

How Much Does BioCryst Pharmaceuticals Make?

Is BioCryst Pharmaceuticals Growing As A Company?

BioCryst Pharmaceuticals Stock Price Performance

What Is BioCryst Pharmaceuticals 52-Week High & Low?

BioCryst Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy BioCryst Pharmaceuticals?

Is BioCryst Pharmaceuticals Cash Flow Positive?

  • What Is BCRX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$55.7M
  • What Is BioCryst Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$4.9M
  • What Is BioCryst Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $6.3M

BioCryst Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    BCRX return on invested capital is -34.87%
  • What Is BioCryst Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -25.05%
  • What Is BCRX Return On Equity?
    ROE is a measure of profitability and is 0%

BioCryst Pharmaceuticals Earnings Date & Stock Price

BioCryst Pharmaceuticals Competitors

BioCryst Pharmaceuticals Dividend Yield

BioCryst Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 17.42%
Revenue: 34.98% 3.92%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 14.82
Upside from Last Price: 86.86%

Major Shareholders

  • How many BCRX shares are owned by institutional investors?
    262.6M BCRX shares are owned by institutional investors
  • How many BCRX shares are owned by insiders?
    6.4M BCRX shares are owned by insiders